Optimization of Cyclosporin in Atopic Dermatitis Through Multiomic Predictive Models of Treatment Response
Status:
Recruiting
Trial end date:
2024-07-01
Target enrollment:
Participant gender:
Summary
This is a low-intervention phase IV trial. The main objective is to optimize the treatment of
patients with moderate-severe atopic dermatitis who require systemic treatment.
Phase:
Phase 4
Details
Lead Sponsor:
Instituto de Investigación Hospital Universitario La Paz